Phase 3 Metabolic Syndrome Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Type 2 Diabetes (T2DM)LipidemiaMetabolic Syndrome (MetS)
NewAmsterdam Pharma300 enrolled20 locationsNCT07219602
Recruiting
Phase 3
Effect of tirzepatide on asthma control in obese asthmatics aged between 18 and 80: An interventional cohort study
ObesityMetabolic SyndromeAsthma
Mater Hospital20 enrolled1 locationACTRN12624001278527
Recruiting
Phase 3
Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment
Metabolic Syndrome
Collegium Medicum w Bydgoszczy200 enrolled1 locationNCT05905965
Completed
Phase 3Phase 4
CoQ10 treatment in inadequately treated hypertensive patients with the metabolic syndrome.
HypertensionThe Metabolic Syndrome
Canterbury Health Laboratories30 enrolled1 locationACTRN12611000241932
Completed
Phase 3
The Antioxidant Study
The Metabolic Syndrome
University of Otago160 enrolled1 locationACTRN12605000744651